Brian Druker
Direktor/Vorstandsmitglied bei AMGEN INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Brian J.
Druker is the founder of MolecularMD Corp.
(founded in 2005) and Blueprint Medicines Corp.
(founded in 2008).
He currently holds multiple positions, including Independent Director at Amgen, Inc. since 2018, Director & Associate Dean at Oregon Health & Science University since 2010, Director at The Burroughs Wellcome Fund, Independent Director at Vincerx Pharma, Inc. since 2020, and Director at OHSU Knight Cancer Institute since 2007.
Dr. Druker's education includes undergraduate and doctorate degrees from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMGEN INC.
0,00% | 31.05.2024 | 6 472 ( 0,00% ) | 2 Mio $ | 30.04.2024 |
VINCERX PHARMA INC
0,20% | 23.05.2024 | 54 806 ( 0,20% ) | 49 161 $ | 30.04.2024 |
Aktive Positionen von Brian Druker
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | Direktor/Vorstandsmitglied | 23.05.2018 |
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 23.12.2020 |
| Oregon Health & Science University | Direktor/Vorstandsmitglied | 01.07.2007 |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Direktor/Vorstandsmitglied | - |
| OHSU Knight Cancer Institute | Direktor/Vorstandsmitglied | 01.07.2007 |
Ehemalige bekannte Positionen von Brian Druker
| Unternehmen | Position | Ende |
|---|---|---|
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Gründer | - |
| BLUEPRINT MEDICINES CORPORATION | Gründer | - |
Ausbildung von Brian Druker
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
| Vincerx Pharma, Inc. | |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
| OHSU Knight Cancer Institute |